A Multimodal Ultrasound-Driven Approach for Automated Tumor Assessment With B-Mode and Multi-Frequency Harmonic...

Harmonic Motion Imaging (HMI) is an ultrasound elasticity imaging method that measures the mechanical properties of tissue using amplitude-modulated acoustic radiation force (AM-ARF). Multi-frequency HMI (MF-HMI) excites tissue at various AM frequencies simultaneously, allowing for image optimization without prior knowledge of inclusion size and stiffness. However, challenges remain in size estimation as inconsistent boundary effects result in different perceived sizes across AM frequencies. Herein, we developed an automated assessment method for tumor and focused ultrasound surgery (FUS) induced lesions using a transformer-based multi-modality neural network, HMINet, and further automated neoadjuvant chemotherapy (NACT) response prediction. HMINet was trained on 380 pairs of MF-HMI and B-mode images of phantoms and in vivo orthotopic breast cancer mice (4T1). Test datasets included phantoms (n = 32), in vivo 4T1 mice (n = 24), breast cancer patients (n = 20), FUS-induced lesions in ex vivo animal tissue and in vivo clinical settings with real-time inference, with average segmentation accuracy (Dice) of 0.91, 0.83, 0.80, and 0.81, respectively. HMINet outperformed state-of-the-art models; we also demonstrated the enhanced robustness of the multi-modality strategy over B-mode-only, both quantitatively through Dice scores and in terms of interpretation using saliency analysis. The contribution of AM frequency based on the number of salient pixels showed that the most significant AM frequencies are 800 and 200 Hz across clinical cases.

We developed an automated, multimodality ultrasound-based tumor and FUS lesion assessment method, which facilitates the clinical translation of stiffness-based breast cancer treatment response prediction and real-time image-guided FUS therapy.